ABBV: This Top Biotech Just Went On A Buying Spree
January 25, 2024 at 07:00 AM EST
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|